On February 11, 2025, the French consumer safety authority Rappel Conso announced a recall of Cherry Pineapple CBD gummies. The recall was initiated due to the detection of Delta-9 tetrahydrocannabinol (D9 THC) in the product. This finding raises concerns regarding compliance with regulatory standards for CBD products, which are expected to contain negligible or non-detectable levels of THC.
The Cherry Pineapple CBD gummies were marketed as a cannabidiol product, and the presence of D9 THC may pose legal and safety implications for consumers. As a result of this incident, consumers are advised to refrain from using the affected gummies and to return them to the point of purchase for a refund or exchange.
The recall emphasizes the importance of quality control in the production of CBD products. Regulatory bodies continue to monitor and enforce standards to ensure consumer safety and product integrity. For further information regarding this recall, consumers can refer to the official communication from Rappel Conso.